Pge 2 recalls
The FDA has published 2 recalls involving Pge 2 since 2014. The latest was reported on 4 May 2022. Most were for sterility. Olympia Compounding Pharmacy has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 4 May 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why pge 2 is recalled
Companies
By year
All pge 2 recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | PGE-2, Alprostadil 80 mcg/mL Multi-Dose vial recalled | Olympia Compounding Pharmacy | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | PGE 2, 100 mcg/mL injectable recalled by Martin Avenue Pharmacy | Martin Avenue Pharmacy | Sterility | Nationwide |
Should you stop taking Pge 2?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.